Medicana Health Group, a luminary in comprehensive healthcare delivery, is set to enter the UK market, aiming to satiate the burgeoning demand for top-tier healthcare services.
As an emblem of superior integrated healthcare, Medicana Health Group is gearing up to broaden its footprint to the UK, deploying its celebrated patient-first ethos and personalised care paradigms. This expansion is strategically aimed at meeting the increased appetite for private healthcare and insurance solutions following the COVID-19 pandemic. At the forefront of Medicana’s mission is a commitment to “active listening and personalised attention,” focusing on understanding and catering to the distinct needs of each patient, thus guaranteeing a tailored healthcare journey from the initial consultation to comprehensive aftercare, with the ambition of transforming the landscape of private healthcare in the UK.
Adhering to the principle of “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group pledges to offer an experience that is both intimately personalised and meticulously curated, drawing on their successful model in Türkiye to spearhead a renaissance in private healthcare within the UK.
Venturing into the £282 Billion UK Healthcare Ecosystem
The revival of the UK’s private healthcare sector in the aftermath of the pandemic has been significantly spurred by an increase in individuals opting for self-payment for healthcare services. An ever-growing number of people are now choosing private healthcare to bypass the extended wait times of the NHS and to benefit from the high calibre and expertise of the independent sector. The Akeso report‘s estimation of the UK’s healthcare expenditure in 2022 stands at £282 billion, with public funding accounting for around 80% and private investments about 20%.
Against this backdrop, Medicana is poised to harness its rich expertise and comprehensive suite of care services to penetrate the UK’s private healthcare market. By bringing its validated care model to the fore, which includes a broad array of diagnostics and specialised treatments, Medicana is well-equipped to fulfil the rising demand for exemplary private healthcare. The group’s steadfast dedication to healthcare excellence, alongside its innovative patient care strategies, positions Medicana as a natural fit for addressing the UK’s healthcare challenges.
Providing Exceptional Care to 5.5 Million Patients Annually
Annually, Medicana Health Group delivers world-class healthcare to over 5.5 million patients globally, leveraging its 16 hospitals equipped with extensive bed capacities. This showcases their vast experience in premium healthcare provision and their adeptness in meeting the complex needs of an international patient cohort. The introduction of Medicana Health Group to the UK market is anticipated to herald a significant shift towards more compassionate, effective, and customised healthcare solutions, marking a new milestone in their enduring commitment to enhancing patient welfare and setting new benchmarks in healthcare standards worldwide.
With a rich heritage spanning more than three decades, Medicana’s medical prowess encompasses a wide range of specialties, offering leading-edge services in areas such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Since 2016, Medicana Health Group has also expanded its footprint in the educational sector, offering a diverse array of educational programmes from preschool to higher education, both in Türkiye and on an international scale.
